drug

Transcranial alternating current stimulation

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by University of Minnesota
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

1
Targeting Individual Alpha Frequencies to Enhance Perceptual Timing
NCT04856657—Completed

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of Minnesota
company
trial
Targeting Individual Alpha Frequencies to Enhance Perceptual Timing
trial
indication
Schizophrenia
indication
Schizo Affective Disorder
indication
Psychosis
indication
Schizophrenia
indication